Journal of Experimental & Clinical Cancer Research seeks manuscripts that include significant advances in basic cancer research and that offer a translational bridge from the laboratory to the clinic to open new avenues for the understanding, prevention, diagnosis and treatment of cancer.Specific areas of interest include, but are not limited to: mechanisms of progression of the malignant phenotype and metastatic disease; molecular alterations or biomarkers that predict response or resistance to treatment; translational research in targeted therapies; personalized medicine; novel applications of bioinformatics and biostatistics; tumor immunotherapy; large-scale molecular characterization of human tumors and innovative methods with potential applicability to clinical investigation.The following criteria provide an overview of the types of studies considered by the journal:Findings that have not been previously published in the same tumor model.Studies performed in multiple cell lines.Conclusions that are not representative of incremental findings.Studies that include a clearly written title and abstract that communicate the study's impact of significance to non-experts.The online appearance of Journal of Experimental & Clinical Cancer Research allows the immediate publication of accepted articles and the presentation of large amounts of data and supplemental information to ensure that new research is disseminated as efficiently and quickly as possible to the scientific community.

《實驗與臨床癌癥研究雜志》尋求包括基礎癌癥研究重大進展的手稿，并提供從實驗室到診所的轉化橋梁，為理解、預防、診斷和治療癌癥開辟新途徑。具體的關注領域包括但不限于：惡性表型和轉移性疾病的進展機制；預測對治療的反應或抗藥性的分子改變或生物標志物；目標療法中的翻譯研究；個性化醫學；生物信息學和生物統計學的新應用；腫瘤免疫治療；人類腫瘤的大規模分子表征和具有臨床應用潛力的創新方法。以下標準概述了該期刊所考慮的研究類型：該研究發現，以前沒有在同一個腫瘤模型中發表過。在多個細胞系中進行的研究。這些結論并不代表漸進的研究結果。研究包括明確的標題和摘要，向非專家傳達研究的重要性。《實驗與臨床癌癥研究雜志》的在線出現使人們能夠立即發表可接受的文章，并提供大量數據和補充信息，以確保新的研究盡可能高效和迅速地傳播到科學界。